TYMPANOGEN, INC.
Richmond, VA · CIK 0001879539 · Medtech · Private
Perf-Fix, a regenerative gel patch for nonsurgical tympanic membrane repair that is applied to the eardrum, cured via blue light into a scaffold, and biodegrades as tissue regenerates
tympanogen.com →- Grants
- $6.2M
- 3 awards
- Sector median: 1
- Raised
- $2.2M
- 3 Form D · Mar 2025
- 19 months since last filing
- Contracts
- $250K
- 1 award · Defense
- #436 of 4531 in medtech
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · A gel patch for replacing surgical eardrum repair with an office-based procedure | $1,479,163 | |
| Federal grant | Department of Health and Human Services · Phase I · A gel patch for replacing surgical eardrum repair with an office-based procedure | $1,479,163 | |
| Federal contract | Department of Defense · Tympanogen's Dha SBIR 19.2 Phase I Medical R&d Purchase Order From Proposal H192-006-0002 For "a Novel Gel Material For Rapid, Point-of-need Tympanic Membrane Repair" | $249,963 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $25,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Clinical study to enable commercialization of nonsurgical gel patch for eardrum repair | $3,235,980 | |
| Private capital raised | Form D · SEC | $1,155,653 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 433 | JBS SCIENCE INC | $274K | — |
| 434 | HYDROCISION INC | $252K | $6.2M |
| 435 | Terapio Corp | $250K | $574K |
| 436 | TYMPANOGEN, INC. | $250K | $2.2M |
| 437 | Akrotome Imaging, INC | $250K | — |
| 438 | Specific Diagnostics, Inc. | $249K | $17M |
| 439 | Otolith Sound Inc | $248K | $31M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Elaine Horn-RanneyDirector · Executive Officer
Patents
- Photocurable Hydrogel Compositionsapplication
- Photocurable Hydrogel Compositionsapplication
- Photocurable Hydrogel Compositionsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.